Fresenius SE Share Holder Equity 2016-2023 | FSNUY

Fresenius SE share holder equity from 2016 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
  • Fresenius SE share holder equity for the quarter ending September 30, 2023 was $32.959B, a 4.19% decline year-over-year.
  • Fresenius SE share holder equity for 2022 was $33.945B, a 2.04% decline from 2021.
  • Fresenius SE share holder equity for 2021 was $34.651B, a 16.57% increase from 2020.
  • Fresenius SE share holder equity for 2020 was $29.726B, a 0.15% decline from 2019.
Fresenius SE Annual Share Holder Equity
(Millions of US $)
2022 $33,945
2021 $34,651
2020 $29,726
2019 $29,770
2018 $18,200
2017 $24,550
2016 $22,597
2015 $19,991
Fresenius SE Quarterly Share Holder Equity
(Millions of US $)
2023-09-30 $32,959
2023-06-30 $34,271
2023-03-31 $34,535
2022-12-31 $33,945
2022-09-30 $34,402
2022-06-30 $34,090
2022-03-31 $34,321
2021-12-31 $34,651
2021-09-30 $33,237
2021-06-30 $32,690
2021-03-31 $33,171
2020-12-31 $29,726
2020-09-30 $30,629
2020-06-30 $30,007
2020-03-31 $29,738
2019-12-31 $29,770
2019-09-30 $29,686
2019-06-30 $28,529
2019-03-31 $29,338
2018-12-31 $18,200
2018-09-30 $17,227
2018-06-30 $17,151
2018-03-31 $17,066
2017-12-31 $24,550
2017-09-30 $24,878
2017-06-30 $23,120
2017-03-31 $23,361
2016-12-31 $22,597
2016-09-30 $21,121
2016-06-30 $20,850
2016-03-31 $19,868
2015-12-31 $19,991
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.911B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $15.437B 15.95
DaVita (DVA) United States $12.399B 15.40
Elanco Animal Health (ELAN) United States $8.920B 23.14
Encompass Health (EHC) United States $8.544B 21.87
Chemed (CHE) United States $8.213B 25.46
Option Care Health (OPCH) United States $4.898B 18.54
RadNet (RDNT) United States $4.340B 90.37
Amedisys (AMED) United States $2.999B 21.24
Astrana Health (ASTH) United States $2.312B 31.26
LifeStance Health (LFST) United States $2.022B 0.00
Addus HomeCare (ADUS) United States $1.939B 27.74
U.S Physical Therapy (USPH) United States $1.388B 37.15
Pennant (PNTG) United States $0.677B 35.75
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Atai Life Sciences (ATAI) Germany $0.224B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.016B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00